stockrowBioCryst Pharmaceuticals, Inc. (BCRX) vs Perrigo Company plc (PRGO)
- BioCryst Pharmaceuticals, Inc. BCRX 7.60 −0.39%
- Perrigo Company plc PRGO 15.82 +0.70%
BioCryst Pharmaceuticals, Inc. and Perrigo Company plc are both Drug Manufacturers Specialty & Generic companies. Perrigo Company plc is the larger, with a market value of $2.2B against $2.0B — 1.1× the size. BioCryst Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 60.3% against −4.47%. BioCryst Pharmaceuticals, Inc. has the higher net margin (−37.4% vs −43.3%) and the higher return on invested capital (0.00% vs −19.0%). Across the 18 metrics below, BioCryst Pharmaceuticals, Inc. leads on 14 and Perrigo Company plc on 4.
Valuation
Profitability
| Metric | BCRX | PRGO | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 97.89% | 32.33% | 53.51% |
| Operating margin | (30.10%) | (39.43%) | 0.00% |
| Net margin | (37.41%) | (43.27%) | (2.45%) |
| Free cash flow margin | 38.11% | 4.11% | 0.00% |
| Return on equity | 91.60% | (51.39%) | (0.80%) |
| Return on assets | (69.33%) | (20.15%) | (1.67%) |
| Return on invested capital | 0.00% | (19.03%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack